1 00:00:05,050 --> 00:00:13,250 My my role now is to hopefully spark a lively debate and discussions that bounce off those two 2 00:00:13,250 --> 00:00:20,630 fantastic presentations and I can see in the Q&A we're starting to get some questions coming through. 3 00:00:20,630 --> 00:00:22,130 We've got about 15 minutes, 4 00:00:22,130 --> 00:00:30,800 so I will try and ask each of the speakers to kind of give quite succinct answers and then we can try and get through as many of the questions we can. 5 00:00:30,800 --> 00:00:38,240 Can I just provoke a question to both of you and sort of use desperately just to sort of ask the first question, 6 00:00:38,240 --> 00:00:42,950 which is when I look at you this year and your last questions you you were 7 00:00:42,950 --> 00:00:48,650 talking about some of the return on investment almost question both governments, 8 00:00:48,650 --> 00:01:00,260 like many governments around the world, are clearly setting, you know, almost wartime levels of public debt in terms of government debt. 9 00:01:00,260 --> 00:01:05,480 So clearly, there is going to be a huge pressure to see return on investment. 10 00:01:05,480 --> 00:01:15,020 I guess the question to both of you, I can see this is both an opportunity for science and technology and research and innovation, 11 00:01:15,020 --> 00:01:18,470 but also want all of the sort of the challenges to that. 12 00:01:18,470 --> 00:01:23,300 So I'll pass to you first and then and then thoughtfully. Sure. 13 00:01:23,300 --> 00:01:30,380 So some of these metrics were for for U.S. laboratories, for private laboratories are required by statute. 14 00:01:30,380 --> 00:01:38,060 So we have to every single research agency has to report, for example, a number of inventions, 15 00:01:38,060 --> 00:01:44,450 number of patents, a number of collaborations, the amount of royalty collected. 16 00:01:44,450 --> 00:01:50,270 And that's one way that we can have metrics that are activity driven, right? 17 00:01:50,270 --> 00:01:56,660 But these metrics are not impact driven. They really don't talk about the impact as much as they talk about the activity. 18 00:01:56,660 --> 00:02:03,740 One of the things that we have found is that so if you were to divide this, you know, 19 00:02:03,740 --> 00:02:09,560 the US portfolio, the hundred fifty billion dollars that goes into the federal R&D into intramural, 20 00:02:09,560 --> 00:02:14,270 which is research that gets done at the agencies by federal employees and 21 00:02:14,270 --> 00:02:19,040 extramural money that's given to universities and nonprofits to do the research. 22 00:02:19,040 --> 00:02:28,310 What you'll see is that we have a lot of activity metrics right on the federal side, on the intramural side, and we have a lot of people. 23 00:02:28,310 --> 00:02:38,000 We have some impact metrics on the extramural side, but we don't have in the way that would truly give you a complete picture and 24 00:02:38,000 --> 00:02:46,280 impact study that would reflect all of the USGS contributions in the R&D arena. 25 00:02:46,280 --> 00:02:54,950 We have studies, for example. Yes, that has been done and its effect on the economy or the fact that some of the some of 26 00:02:54,950 --> 00:03:00,230 the areas of research in the US government have spurred actually industries right. 27 00:03:00,230 --> 00:03:05,600 But we haven't done impact studies on those as much as we have done on the real side. 28 00:03:05,600 --> 00:03:13,310 Conversely, we have a lot of activity metrics utterly, yes. 29 00:03:13,310 --> 00:03:24,560 So I agree. Having really convincing indicators for all on government investment decisions, 30 00:03:24,560 --> 00:03:33,260 I think is crucial and they are really difficult to get high quality ones in the research innovation system particularly dynamically. 31 00:03:33,260 --> 00:03:41,600 And the relationship between the inputs and the impact of real outcomes at the other end is quite complicated. 32 00:03:41,600 --> 00:03:50,570 And so although there are incredibly robust arguments that demonstrate that public sector investment 33 00:03:50,570 --> 00:03:59,730 really does both crowd in private sector investment and drive up productivity and all of these things, 34 00:03:59,730 --> 00:04:09,890 the the the instant returns are definitely what is very hard to do that falls. 35 00:04:09,890 --> 00:04:17,240 And so essentially the arguments that we need to be making all this once in a generation opportunity, 36 00:04:17,240 --> 00:04:26,640 in the context of the instability of the pandemic and economic instability to invest in that long for high quality, 37 00:04:26,640 --> 00:04:39,050 high productivity economy, which will only come from or an innovation that and it's I agree it's incredibly challenging 38 00:04:39,050 --> 00:04:48,830 to make because it's in the context of massive national debt and and social inequality. 39 00:04:48,830 --> 00:04:58,760 So there's an obvious desire to invest much more straightforwardly in in short term things. 40 00:04:58,760 --> 00:05:04,980 But these short term things like short term and they will not last and they will not build the long term. 41 00:05:04,980 --> 00:05:10,230 Ambitions of a more equal and inclusive innovation led economy, 42 00:05:10,230 --> 00:05:18,540 which is a positive feedback loop that it will build on itself unless you start that feedback and you will go nowhere. 43 00:05:18,540 --> 00:05:27,900 So it's a it's a moment of it's really a key moment of opportunity to shift to that long term. 44 00:05:27,900 --> 00:05:37,320 Long term, productive, inclusive economy rather than a short term approach, which has attractions. 45 00:05:37,320 --> 00:05:44,600 You can see why it's attractive and it's not. It's just people that tend to propose that we need. 46 00:05:44,600 --> 00:05:53,310 So it's time to do our best to make sure that it's an investment in the future. 47 00:05:53,310 --> 00:05:58,080 Excellent. Thank you. I've got one question from the audience. 48 00:05:58,080 --> 00:06:05,960 We've obviously talked today about international collaboration, in particular focussing on the opportunities between the UK and the US. 49 00:06:05,960 --> 00:06:11,430 And there's been a lot of discussion actually and results of the G7 meeting about 50 00:06:11,430 --> 00:06:15,060 international collaboration in partnership with the rest parts of the world, 51 00:06:15,060 --> 00:06:19,740 especially on vaccine taste. 52 00:06:19,740 --> 00:06:28,920 I wonder what both of you thought about and the sort of international outlook and how we sort of almost use research and innovation, 53 00:06:28,920 --> 00:06:37,470 science and technology for good on a global stage? 54 00:06:37,470 --> 00:06:41,660 We're meant to do this to a new lead, the batting this time. 55 00:06:41,660 --> 00:06:53,970 So this is a number of lines for international collaboration and as a funding agency, we we we have this issue in this one. 56 00:06:53,970 --> 00:06:54,720 On the one hand, 57 00:06:54,720 --> 00:07:04,230 there's the researchers and innovators and folks who are very motivated to collaborate to access the best ideas that there are around the world, 58 00:07:04,230 --> 00:07:08,670 and that looks at what drives something that's really important and and builds 59 00:07:08,670 --> 00:07:13,320 networks internationally that have both direct and indirect consequences, 60 00:07:13,320 --> 00:07:19,560 incredible cooperation, all the things we need to foster. We need to do that in a way that is mindful security talks. 61 00:07:19,560 --> 00:07:30,060 And that's in some ways a particularly complex part of the equation to navigate because it is very spontaneous and Bottom-Up generated. 62 00:07:30,060 --> 00:07:37,680 And then there's something that you can think of is more top down where there are a national priorities, 63 00:07:37,680 --> 00:07:43,470 either to build specific collaborations or to drive particular on all objectives. 64 00:07:43,470 --> 00:07:45,540 And from that again, 65 00:07:45,540 --> 00:07:58,080 I think this is a very interesting navigation between where a bunch of countries who are very aligned values and interests in a particular area. 66 00:07:58,080 --> 00:08:02,520 How can we most effectively use our on joint assets, 67 00:08:02,520 --> 00:08:07,920 both in terms of public investments and expertise and infrastructures to move all the benefits forward? 68 00:08:07,920 --> 00:08:16,650 That's great. But then there's a huge amount of discussion about just how can you use these research and innovation collaborations 69 00:08:16,650 --> 00:08:26,250 in the context of both nations with humans trying to build relationships and investigate the alignment of values? 70 00:08:26,250 --> 00:08:39,180 And that's what's also interesting domain to explore because again, balancing the science and innovation objectives, 71 00:08:39,180 --> 00:08:43,680 we've actually have something that's more of a diplomatic objective. 72 00:08:43,680 --> 00:08:48,630 And and how one carefully marries these things. 73 00:08:48,630 --> 00:08:54,360 But I think we, as I said this from funders of research, 74 00:08:54,360 --> 00:09:03,570 innovation and mission collaborations are all in constantly trying to balance these various priorities, 75 00:09:03,570 --> 00:09:18,220 particularly again in the context of specific budget and how you decide to invest them to meet all of these multiple pages is quite so much. 76 00:09:18,220 --> 00:09:22,110 Definitely us. I agree wholeheartedly. 77 00:09:22,110 --> 00:09:28,440 I think it's a delicate balance of trying to. This is science diplomacy at its best, right? 78 00:09:28,440 --> 00:09:33,120 Where we are, we are doing a pandemic this. There's nothing more precious than human life. 79 00:09:33,120 --> 00:09:38,550 And to want to protect that using the results of R&D, be it public or private. 80 00:09:38,550 --> 00:09:46,950 I think it's it's it's a goal of everyone. But how do you how do you balance that against other R&D considerations? 81 00:09:46,950 --> 00:09:55,950 And you know, you know, a debate that has come up prior to the G7 was, you know, what was that? 82 00:09:55,950 --> 00:10:00,360 What was the world of intellectual property? And how do we how do we look at that? 83 00:10:00,360 --> 00:10:04,780 And does it does it even? Should we be talking about that, right? 84 00:10:04,780 --> 00:10:12,630 So it's it's a delicate balance between what science is there to do, which is to do good right? 85 00:10:12,630 --> 00:10:17,480 And and what does what are the larger implications should there be another pandemic? 86 00:10:17,480 --> 00:10:22,840 And where does one draw the line, even if it's clear in this case? 87 00:10:22,840 --> 00:10:28,690 Are there other cases that we would need to? We would need to think about this delicate balance. 88 00:10:28,690 --> 00:10:33,450 But but but I also do know that during the G7, 89 00:10:33,450 --> 00:10:41,760 there was the commitment that was reiterated in very specific terms about reaching out and making sure that countries are committed. 90 00:10:41,760 --> 00:10:50,820 The G7 countries are committed to to providing vaccines to other countries as well. 91 00:10:50,820 --> 00:10:55,390 So, yeah, delicately well put by both of you. 92 00:10:55,390 --> 00:11:05,810 I'm just with five minutes to go my my e-mail questions coming in, but I would just like both of you to just help me set up the breakout sessions. 93 00:11:05,810 --> 00:11:13,620 And we've we've we've tasked this esteemed audience to think about both the opportunities and challenges 94 00:11:13,620 --> 00:11:20,010 from international collaboration and and and I'm hopefully going put some words in your mouth, 95 00:11:20,010 --> 00:11:24,600 but it feels to me that both of you have all very eloquently articulated. 96 00:11:24,600 --> 00:11:29,310 Actually, this is an immensely exciting time when governments are really putting us. 97 00:11:29,310 --> 00:11:35,550 Both governments are putting a spotlight on this on this agenda, both of science, research technology. 98 00:11:35,550 --> 00:11:41,460 It's also about opportunities for collaboration, both at home and abroad. 99 00:11:41,460 --> 00:11:47,370 I guess my hope is that both the breakout groups will give you lots of ideas. 100 00:11:47,370 --> 00:11:51,090 I guess the might my ask of you is what do you want? 101 00:11:51,090 --> 00:11:56,430 What would you like to hear from those groups? You know all the. Are you looking for more ideas? 102 00:11:56,430 --> 00:12:00,810 Are you looking for radical ideas? Are you looking for? 103 00:12:00,810 --> 00:12:05,340 But also, do you want to hear about some of the challenges? 104 00:12:05,340 --> 00:12:09,660 Invariably, these could be very closed questions, and so I'm hoping that you will elaborate a little bit. 105 00:12:09,660 --> 00:12:19,380 But I it feels to me that there is a lot of opportunities here, but it will require us to probably think differently, act differently. 106 00:12:19,380 --> 00:12:25,270 Over to you. I'll start with our colleagues from the US and Iceland to wrap up. 107 00:12:25,270 --> 00:12:35,730 So I certainly would be very interested in hearing about the challenges and and to be able to separate what challenges or myths, 108 00:12:35,730 --> 00:12:39,510 because sometimes we think something is a challenge because it wasn't done before. 109 00:12:39,510 --> 00:12:45,750 We believe that it can't be done right. So what are the myths in the challenge category and what are the actual challenges? 110 00:12:45,750 --> 00:12:55,830 What are the things that we actually need to think about? What are the, you know, are these challenges that are so to give you an example, 111 00:12:55,830 --> 00:13:00,480 you know, there is there is belief on funding that most funding cannot be. 112 00:13:00,480 --> 00:13:08,070 There is funding that is within a certain jurisdiction. So, you know, you know, agencies that fund within a certain jurisdiction. 113 00:13:08,070 --> 00:13:17,220 Is that necessarily the case? Can one collaborate if one is a is not combat jurisdiction, they might not be the grant recipient. 114 00:13:17,220 --> 00:13:21,660 But does that mean they can collaborate? And the answer is sometimes yes, sometimes no. 115 00:13:21,660 --> 00:13:27,720 So to make sure that we limit the scope of our challenges to what the challenges actually are, 116 00:13:27,720 --> 00:13:32,520 rather than to expand it to include the things that might not be. 117 00:13:32,520 --> 00:13:36,330 So that would be my ask do not not just identify them, 118 00:13:36,330 --> 00:13:48,570 but maybe even explore what are true challenges and what are myths or things that we culturally believe in in the in the R&D, 119 00:13:48,570 --> 00:13:56,400 in the R&D world and might not necessarily be a hindrance or could be worked out? 120 00:13:56,400 --> 00:14:03,520 Absolutely, I would. I would agree with that. And I think another one of the reasons this is an exciting time and it's exciting 121 00:14:03,520 --> 00:14:08,670 for all kinds of things are extraordinary opportunities in research innovation, 122 00:14:08,670 --> 00:14:15,240 just amazing breakthroughs and and and new tools and technologies. 123 00:14:15,240 --> 00:14:22,320 Huge at what's the government alignment research innovation is crucial. 124 00:14:22,320 --> 00:14:32,550 That's the kind of massive instability caused by the pandemic, which allows for the first and the change in a very positive way. 125 00:14:32,550 --> 00:14:40,620 And I think the other thing that we've learnt from the pandemic is exactly that a lot of our assumptions and incense and if we want to. 126 00:14:40,620 --> 00:14:45,090 And so taking that moment of opportunity, I think, is great. 127 00:14:45,090 --> 00:14:52,140 But so, yes, to do everything already suggested in the context of challenges. 128 00:14:52,140 --> 00:14:59,280 But I'm also very I would be also interested in opportunities that specific opportunities that people 129 00:14:59,280 --> 00:15:10,170 see that we can with the commission and the how you how you do the job that we've all talked about, 130 00:15:10,170 --> 00:15:19,690 how you manage to balance some of the amazing ambitions for collaboration with the concerns about security, 131 00:15:19,690 --> 00:15:27,720 but anything that associated with this lack of bedtimes? 132 00:15:27,720 --> 00:15:35,700 Excellent. Well, thank you to you both. And this has been a fantastic session in terms of insights and others. 133 00:15:35,700 --> 00:15:39,840 I'm going to on behalf of both the conference organisers and all the delegates here today. 134 00:15:39,840 --> 00:15:43,110 Thank you for your presentations and your insights. 135 00:15:43,110 --> 00:15:51,540 And I will I will ask you now you can both segments successfully kind of exit off the stage, but thank you to you both. 136 00:15:51,540 --> 00:15:54,330 If if we wrote the Oxford College of Choice, 137 00:15:54,330 --> 00:15:59,190 we would have been collecting you and saying thank you very much and inviting you for a drink at some point. 138 00:15:59,190 --> 00:16:04,840 But hopefully we can do that next year. So thank you very much, device. And then I'll pick up the second. 139 00:16:04,840 --> 00:16:14,976 I'll set up the breakout session, so thank you. Thank you.